期 |
栏目 |
标题 |
文件 |
编号 13 (2015) |
Articles |
Chastota naznacheniya potentsial'no ne rekomendovannykh lekarstvennykh preparatov (po kriteriyam «STOPP START») pozhilym patsientam, nakhodyashchimsya v terapevticheskikh otdeleniyakh statsionara: rezul'taty farmakoepidemiologicheskogo issledovaniya |
|
卷 27, 编号 5 (2020) |
Articles |
«PharmaCOVID» - information center for pharmacotherapy of patients with new coronavirus infection COVID-19 |
|
卷 27, 编号 5 (2020) |
Articles |
Drug-induced diseases: epidemiology and urgency of the problem |
|
卷 27, 编号 6 (2020) |
Articles |
Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance |
|
卷 27, 编号 14 (2020) |
Articles |
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19 |
|
卷 28, 编号 1 (2021) |
Articles |
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide |
|
卷 28, 编号 1 (2021) |
Articles |
Possibility and prospects of using bamlanivimab in patients with COVID-19 |
|
卷 28, 编号 3 (2021) |
Articles |
Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system |
|
卷 28, 编号 3 (2021) |
Articles |
The influence of CYP2C9 gene polymorphisms on the efficacy of losartan in patients with grade I-II arterial hypertension |
|
卷 28, 编号 3 (2021) |
Articles |
Carriage of the COMT rs4680 polymorphic variant is associated with better tolerance to antipsychotics in adolescents with an acute psychotic episode: a prospective observational clinical study |
|
卷 28, 编号 5 (2021) |
Articles |
Tobacco smoking as a risk factor for the development of drug-induced diseases |
|
卷 28, 编号 9 (2021) |
Articles |
Polymorphic variants of the ANKS1B rs7968606 (C>T) and ZNF804A rs1344706 (G>T) genes are not associated with the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode |
|
卷 28, 编号 9 (2021) |
Articles |
HTR2A rs6313 polymorphic variant is associated with adverse effects to antipsychotics in adolescents with an acute psychotic episode |
|
卷 28, 编号 10 (2021) |
Articles |
Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19 |
|
卷 28, 编号 11 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors |
|
卷 28, 编号 11 (2021) |
Articles |
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode |
|
卷 28, 编号 11 (2021) |
Articles |
Medication errors as risk factor for drug-induced diseases |
|
卷 28, 编号 12 (2021) |
Articles |
Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19 |
|
卷 28, 编号 12 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors |
|
卷 28, 编号 13 (2021) |
Articles |
Drug-alcohol interactions: focus on central-acting drugs and analgesics |
|
卷 28, 编号 13 (2021) |
Articles |
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs |
|
卷 28, 编号 13 (2021) |
Articles |
Effect of CYP2C9 gene polymorphism on losartan dosage regimen in patients with I-II degree arterial hypertension |
|
卷 29, 编号 1 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions |
|
卷 29, 编号 3 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence |
|
卷 29, 编号 3 (2022) |
Articles |
Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status |
|
卷 29, 编号 13 (2022) |
Articles |
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins |
|